Clinic
Western Montana Clinic PC
Western Montana Clinic PC was paid $8.68M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoWESTERN MONTANA CLINIC PC
MISSOULA, MT 59802
MISSOULA, MT 59802
33aNPI1942253182assigned 05/18/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$8.68M
24GClaims122,937
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Montana
Rank by total paid#1 of 23
Median peer was paid$299K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,500 | $1.47M | |
| 2019 | 21,903 | $1.39M | |
| 2020 | 14,020 | $880K | |
| 2021 | 15,224 | $1.14M | |
| 2022 | 17,658 | $1.46M | |
| 2023 | 15,545 | $1.36M | |
| 2024incomplete | 11,087 | $966K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 31,448 | 29,239 | $2.60M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 17,429 | 16,461 | $1.82M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 7.9% | 3,270 | 3,020 | $682K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 6.2% | 2,440 | 2,341 | $535K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.4% | 2,597 | 2,510 | $470K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 3,296 | 3,099 | $371K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.2% | 2,416 | 2,286 | $280K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 2,256 | 2,121 | $241K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.4% | 1,187 | 1,135 | $212K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 10,491 | 9,626 | $206K |
| 93320 | 1.8% | 3,255 | 3,015 | $159K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.5% | 5,171 | 4,685 | $127K |
65 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.2% | 1,516 | $107K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 7,048 | $83K |
| 93000 | <1% | 4,554 | $79K | |
| 93325 | <1% | 3,385 | $72K | |
| 90670 | <1% | 1,636 | $62K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,425 | $62K |
| 99205 | Prolong outpt/office vis | <1% | 323 | $60K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 452 | $55K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 24 | $45K |
| 93356 | <1% | 933 | $39K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 256 | $34K |
| 90686 | <1% | 3,667 | $24K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 226 | $23K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 443 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,165 | $17K |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 3,872 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 638 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 293 | $14K |
| 90723 | <1% | 824 | $14K | |
| 95811 | <1% | 120 | $11K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 435 | $10K |
| 90651 | <1% | 104 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 613 | $9K |
| 17110 | <1% | 77 | $9K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 88 | $9K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 145 | $8K |
| 90681 | <1% | 200 | $7K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 33 | $6K |
| 90647 | <1% | 790 | $4K | |
| 11100 | <1% | 53 | $4K | |
| 11102 | <1% | 57 | $4K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 29 | $3K |
| 99443 | <1% | 40 | $3K | |
| 90474 | <1% | 199 | $3K | |
| 90633 | <1% | 234 | $2K | |
| 90710 | <1% | 12 | $2K | |
| 90734 | <1% | 41 | $2K | |
| 92551 | <1% | 130 | $2K | |
| 0001A | <1% | 63 | $2K | |
| 0002A | <1% | 48 | $1K | |
| 90715 | <1% | 72 | $1K | |
| 99442 | <1% | 29 | $1K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $1K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 19 | $989.69 |
| 96415 | <1% | 29 | $963.04 | |
| 90656 | <1% | 237 | $960.00 | |
| 90677 | <1% | 15 | $776.55 | |
| 94664 | <1% | 36 | $629.78 | |
| 99441 | <1% | 14 | $614.04 | |
| 91200 | <1% | 15 | $515.08 | |
| 90696 | <1% | 12 | $495.70 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 17 | $479.15 |
| S0315 | Disease management program; initial assessment and initiation of the program | <1% | 62 | $465.00 |
| 94010 | <1% | 29 | $460.58 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 43 | $448.42 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 42 | $291.93 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 400 | $246.89 |
| 99173 | <1% | 79 | $229.34 | |
| 81002 | <1% | 73 | $216.32 | |
| 94726 | <1% | 25 | $210.71 | |
| 90685 | <1% | 18 | $165.33 | |
| 90700 | <1% | 15 | $113.65 | |
| 94729 | <1% | 12 | $86.76 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 12 | $65.08 |
| 99177 | 0% | 173 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOTTMAN, DIRK (PRESIDENT)